Harbor Investment Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Harbor Investment Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2	Closed	–	–	1328
2021 Q1	$0	Hold	2	–	–	﹤0.01%	1332
2020 Q4	$0	Hold	2	–	–	﹤0.01%	1268
2020 Q3	$0	Hold	2	–	–	﹤0.01%	1280
2020 Q2	$0	Sell	2 -1,117	-100%	-$127K	﹤0.01%	1245
2020 Q1	$98K	Buy	1,119 +1,117	+55,850%	+$118K	0.03%	316
2019 Q4	$0	Buy	+2	New	+$224	﹤0.01%	1032

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Harbor Investment Advisory's GWPH Position: Q2 2021 in Review

Harbor Investment Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2 shares.

Harbor Investment Advisory first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $98K in Q1 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Harbor Investment Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Harbor Investment Advisory sold 2 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021.
Harbor Investment Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Harbor Investment Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $98K in Q1 2020.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Harbor Investment Advisory's 13F filing for Q2 2021, filed 27 Jul 2021.